收费全文 | 7565篇 |
免费 | 605篇 |
国内免费 | 156篇 |
耳鼻咽喉 | 35篇 |
儿科学 | 228篇 |
妇产科学 | 62篇 |
基础医学 | 456篇 |
口腔科学 | 38篇 |
临床医学 | 1236篇 |
内科学 | 823篇 |
皮肤病学 | 151篇 |
神经病学 | 340篇 |
特种医学 | 167篇 |
外科学 | 1597篇 |
综合类 | 1029篇 |
预防医学 | 415篇 |
眼科学 | 49篇 |
药学 | 1371篇 |
12篇 | |
中国医学 | 129篇 |
肿瘤学 | 188篇 |
2024年 | 8篇 |
2023年 | 116篇 |
2022年 | 168篇 |
2021年 | 266篇 |
2020年 | 276篇 |
2019年 | 255篇 |
2018年 | 276篇 |
2017年 | 257篇 |
2016年 | 227篇 |
2015年 | 236篇 |
2014年 | 431篇 |
2013年 | 504篇 |
2012年 | 411篇 |
2011年 | 390篇 |
2010年 | 358篇 |
2009年 | 296篇 |
2008年 | 382篇 |
2007年 | 340篇 |
2006年 | 300篇 |
2005年 | 281篇 |
2004年 | 213篇 |
2003年 | 186篇 |
2002年 | 186篇 |
2001年 | 150篇 |
2000年 | 128篇 |
1999年 | 115篇 |
1998年 | 99篇 |
1997年 | 118篇 |
1996年 | 117篇 |
1995年 | 100篇 |
1994年 | 99篇 |
1993年 | 96篇 |
1992年 | 90篇 |
1991年 | 100篇 |
1990年 | 75篇 |
1989年 | 48篇 |
1988年 | 98篇 |
1987年 | 62篇 |
1986年 | 46篇 |
1985年 | 77篇 |
1984年 | 57篇 |
1983年 | 40篇 |
1982年 | 53篇 |
1981年 | 44篇 |
1980年 | 35篇 |
1979年 | 20篇 |
1978年 | 17篇 |
1977年 | 20篇 |
1976年 | 15篇 |
1975年 | 15篇 |
Objective
The “Centre Hospitalier Francois Dunan” is located on an isolated island and ensures patients care in hemodialysis thanks to telemedicine support. Many research studies have demonstrated the importance of hemodialysis fluids composition to reduce morbidity in patients on chronic hemodialysis. The aim of this study was to identify the risks inherent in the production of dialysis fluids in a particular context, in order to set up an improvement action plan to improve risk control on the production of dialysis fluids.Methods
The risk analysis was conducted with the FMECA methodology (Failure Mode, Effects and Criticality Analysis) by a multi professional work group. Three types of risk have been reviewed: technical risks that may impact the production of hemodialysis fluids, health risks linked with chemical composition and health risks due to microbiological contamination of hemodialysis fluids.Results
The work group, in close cooperation with the expert staff of the dialysis center providing telemedicine assistance, has developed an action plan in order to improve the control of the main risks brought to light by the risk analysis.Conclusion
The exhaustive analysis of the risks and their prioritisation have permitted to establish a relevant action plan in this improving quality of dialysis fluids approach. The risk control of dialysis fluids is necessary for the security of dialysis sessions for patients, even more when these sessions are realized by telemedicine in Saint-Pierre-et-Miquelon. 相似文献Background
The intravenous thrombolysis (IVT) with recombinant tissue plasminogen activator (rt-PA) therapy is safe and efficient during the treatment of acute ischemic stroke. Nonetheless, the different outcomes among various stroke subgroups have limited data with regard to the safety and efficacy of cryptogenic stroke (CS). The present study compared the safety and efficacy when IVT with rt-PA was used for the treatment of CS and the other stroke subtypes.Methods
This study classified the IVT with rt-PA patients within 4.5 hours after stroke onset, based on the trial of ORG 10172 in acute stroke treatment criteria in terms of diagnostic evaluation. The data were obtained from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China database, a large multicenter prospective registry. A multivariable logistic regression model was employed to compare the differences between the subtypes in symptomatic intracerebral hemorrhage (sICH) within 7 days and studied the mortality and the outcome during 90 days.Results
In total, 1118 patients were recruited; of these, 131 (11.7%) suffered from CS and 987 (88.3%) with the other etiology. In the CS group, patients were younger than those in the other etiology groups (P < .001). Moreover, it had a lower prevalence of previous stroke (P?=?.0117), receiving antiplatelet drug in 24 hours prior to thrombolysis (P?=?.0017), and functional independence (mRS > 1 before stroke, P?=?.003). The CS group had lower blood pressure (systolic blood pressure P?=?.0001; diastolic blood pressure; P?=?.0212) before thrombolysis, atrial fibrillation (P < .001), and diabetes mellitus (P?=?.0005). Transient ischemic attack, hypertension, hyperlipidemia, blood glucose, receiving anticoagulants in 24 hours prior to thrombolysis, and standard dosage of rt-PA were equally distributed in both groups. After the adjustment of confounders between the CS and the other subgroups, no obvious differences were observed in sICH rate and mortality (P > .05) The CS patients exhibited excellent recovery (mRS, 0-1; 63.78%) and functional independence (mRS, 0-2; 74.8%) than the large artery atherosclerosis patients.Conclusions
IVT with rt-PA is a safe and effective method for the treatment of CS patients. 相似文献2. The CGA is administered intravenously (IV) and intranasally (IN) at the dose of 10?mg/kg. Further, its concentration in the plasma, cerebrospinal fluid (CSF) and the whole brain is analyzed by HPLC-UV method.
3. The study observes that CGA is rapidly absorbed in plasma with tmax of 1?min similar to IV route after IN administration. The peak plasma concentration and AUC0–24 are higher by 3.5 and 4.0 times respectively in IV administration, compared to IN delivery that represents the significant less systemic exposure of CGA in IN route.
4. However, the concentration of CGA in the brain is 4, 6.5, 5.3, 5.2 and 4.5 times higher at 30, 60, 120, 240 and 360?min, respectively in IN administration compared to IV administration. The exposure of CGA in the brain after IN administration (AUCbrain, IN) was significantly greater (4 times) as compared to the exposure of CGA in the brain (AUCbrain, IV) after IV administration reflecting significant brain uptake of CGA through nasal route. Therefore, IN delivery of CGA can be a promising approach for the treatment of stroke and neurodegenerative disorders. 相似文献